Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: An in vitro study

Arthritis and Rheumatism

Volumn 56, Issue 1, 2007, Pages 199-207

  Jansen, Nathalie W D ^a   Roosendaal, Goris ^a   Bijlsma, Johannes W J ^a   DeGroot, Jeroen ^b   Lafeber, Floris P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

ARTICLE; ARTICULAR CARTILAGE; BLEEDING; CONCENTRATION RESPONSE; DNA CONTENT; EXTRACELLULAR MATRIX; HEMARTHROSIS; HUMAN; HUMAN TISSUE; JOINT INJURY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

BLOOD; BLOOD PROTEINS; CARTILAGE, ARTICULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MATRIX METALLOPROTEINASES; MIDDLE AGED; PROTEOGLYCANS; TIME FACTORS;

EID: 33846213961     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22304     Document Type: Article

References (39)

1. Luck JV Jr, Silva M, Rodriguez-Merchan EC, Ghalambor N, Zahiri CA, Finn RS. Hemophilic arthropathy. J Am Acad Orthop Surg 2004;12:234-45.
2. Stein H, Duthie RB. The pathogenesis of chronic haemophilic arthropathy. J Bone Joint Surg Br 1981;63B:601-9.
3. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997;24:1350-4.
4. Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 1999;42:1025-32.
5. Tajima T, Yoshida E, Yamashita A, Ohmura S, Tomitaka Y, Sugiki M, et al. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage. J Orthop Res 2005;23:891-8.
6. Roosendaal G, van Rinsum AC, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Histopathology 1999;34:144-53.
7. Ghosh P, Smith M. Osteoarthritis: genetic and molecular mechanisms. Biogerontology 2002;3:85-8.
8. Van Valburg AA, Wenting MJ, Beekman B, Te Koppele JM, Lafeber FP, Bijlsma JW. Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: comparison with clinically defined osteoarthritic cartilage. J Rheumatol 1997; 24:358-64.
9. Hooiveld M, Roosendaal G, Wenting M, van den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003;162:943-51.
10. Hooiveld MJ, Roosendaal G, van den Berg HM, Bijlsma JW, Lafeber FP. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study. Rheumatology (Oxford) 2003;42:784-90.
11. Hooiveld M, Roosendaal G, Vianen M, van den Berg H, Bijlsma J, Lafeber F. Blood-induced joint damage: longterm effects in vitro and in vivo. J Rheumatol 2003;30:339-44.
12. Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998;47: 477-86.
13. Muirden KD, Peace G, Rogers K. Clearance of Fe59-labelled erythrocytes from normal and inflamed rabbit knee joints: II. Autoradiographic and histological studies. Ann Rheum Dis 1969; 28:630-6.
14. Muirden KD. Clearance of Fe59-labelled erythrocytes from normal and inflamed rabbit knee joints: I. Relationship to the anaemia of rheumatoid arthritis. Ann Rheum Dis 1969;28:548-51.
15. Hooiveld MJ, Roosendaal G, Jacobs KM, Vianen ME, van den Berg HM, Bijlsma JW, et al. Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy. Arthritis Rheum 2004;50:2024-31.
16. Roosendaal G, Tekoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999;42:1033-9.
17. Ingram GI, Mathews JA, Bennett AE. A controlled trial of joint aspiration in acute haemophilic haemarthrosis. Br J Haematol 1972;23:649-54.
18. Ingram GI, Mathews JA, Bennett AE. Controlled trial of joint aspiration in acute haemophilic haemarthrosis. Ann Rheum Dis 1972;31:423.
19. Holdsworth BJ, Clement DA, Rothwell PN. Fractures of the radial head-the benefit of aspiration: a prospective controlled trial. Injury 1987;18:44-7.
20. Van Valburg AA, Wenting MJ, Beekman B, te Koppele JM, Lafeber FP, Bijlsma JW. Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: comparison with clinically defined osteoarthritic cartilage. J Rheumatol 1997; 24:358-64.
21. Mastbergen SC, Bijlsma JW, Lafeber FP. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Osteoarthritis Cartilage 2005;13: 519-26.
22. Whiteman P. The quantitative determination of glycosaminoglycans in urine with Alcian Blue SGX. Biochem J 1973;131:351-7.
23. Whiteman P. The quantitative measurement of Alcian Blue-glycosaminoglycan complexes. Biochem J 1973;131:343-50.
24. Riley GP, Curry V, DeGroot J, van El B, Verzijl N, Hazleman BL, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002; 21:185-95.
25. Beekman B, Drijfhout JW, Bloemhoff W, Ronday HK, Tak PP, te Koppele JM. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett 1996;390:221-5.
26. Beekman B, Drijfhout JW, Ronday HK, Tekoppele JM. Fluorogenic MMP activity assay for plasma including MMPs complexed to α2-macroglobulin. Ann N Y Acad Sci 1999;878:150-8.
27. Lafeber FP, van Roy H, Wilbrink B, Huber-Bruning O, Bijlsma JW. Human osteoarthritic cartilage is synthetically more active but in culture less vital than normal cartilage. J Rheumatol 1992;19: 123-9.
28. Rodriguez-Merchan EC. The destructive capabilities of the synovium in the haemophilic joint. Haemophilia 1998;4:506-10.
29. Roosendaal G, Vianen ME, Wenting MJ, van Rinsum AC, van den Berg HM, Lafeber FP, et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998;80:540-5.
30. Roosendaal G, Mauser-Bunschoten EP, de Kleijn P, Heijnen L, van den Berg HM, van Rinsum AC, et al. Synovium in haemophilic arthropathy. Haemophilia 1998;4:502-5.
31. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999;344:61-8.
32. Caterson B, Flannery CR, Hughes CE, Little CB. Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol 2000; 19:333-44.
33. Arner EC. Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2002;2:322-9.
34. Mort JS, Billington CJ. Articular cartilage and changes in arthritis: matrix degradation. Arthritis Res 2001;3:337-41.
35. Nagase H, Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003;5:94-103.
36. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992;6:861-70.
37. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001;12:69-78.
38. Nietfeld JJ. Cytokines and proteoglycans. Experientia 1993;49: 456-69.
39. Roughley PJ, Lee ER. Cartilage proteoglycans: structure and potential functions. Microsc Res Tech 1994;28:385-97.